Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Satomu Morita
Osimertinib Treatment Was Unsuccessful for Lung Adenocarcinoma With G719S, S768I, and T790M Mutations
Internal Medicine
Internal Medicine
Medicine
Related publications
EGFR T790M Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Lung Adenocarcinoma Patients With Acquired Resistance to First Generation EGFR Tyrosine Kinase Inhibitors
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
In Silico Insight Into EGFR Treatment in Patients With Lung Carcinoma and T790M Mutations
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Triple Mutation Epidermal Growth Factor Receptor (EGFR) Exon 18 (G719S), 20 (T790M) and 21 (L858R) in a Male Patient With Lung Adenocarcinoma: A Case Report
Jurnal Respirasi
Overcoming T790M Mutant Small Cell Lung Cancer With the Third-Generation EGFR-TKI Osimertinib
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients
Oncology Reports
Medicine
Cancer Research
Oncology
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation
Cancers
Cancer Research
Oncology
Osimertinib (AZD9291) Increases Radio‑sensitivity in EGFR T790M Non‑small Cell Lung Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient With Lung Adenocarcinoma Following Treatment With Erlotinib and Osimertinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients With EGFR T790m-Positive NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
